Advertisement

Advertisement

Most Viewed Videos
Jedd D. Wolchok, MD, PhD, on The Future of Immunotherapy: Keynote Lecture
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Pieter Tanis, MD, PhD, on Colon Cancer: Results From the COLOPEC Trial on Adjuvant HIPEC
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
Martin Edelman, MD, on Immunotherapy: How Safe Is It for Patients With Autoimmune Disease?
Nicholas Vogelzang, MD, on Urothelial Cancer: Results From a Trial on Lenvatinib Plus Pembrolizumab
Brian I. Rini, MD, on Renal Cell Cancer: Risk Stratification After Resection of Localized Disease
Jyoti D. Patel, MD, on Stage III Non–Small Cell Lung Cancer: A Look at New Systemic Treatments
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Wells A. Messersmith, MD, on Managing Metastatic Colorectal Cancer: NCCN Guidelines Update
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
Heinz-Josef Lenz, MD, on Pancreatic Cancer Tumor Profiling and Treatment Response: Results From the COMPASS Trial
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
Heather A. Wakelee, MD, on Advanced Non–Small Cell Lung Cancer: State-of-the-Art Treatment for EGFR-Positive and ALK-Positive Diseases
Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
Rana R. McKay, MD, on Renal Cell Carcinoma: Results From a Trial on Atezolizumab and Bevacizumab
Neil P. Shah, MD, PhD, on CML: NCCN Guidelines Updates on Discontinuing Tyrosine Kinase Inhibitor Therapy
Sara A. Hurvitz, MD, on HER2-Positive Breast Cancer: Novel Treatments and Markers

Advertisement

Advertisement



;
Advertisement